Hemispherx (HEB) Shares Down 15% Today and Down 45% Over Last Two Weeks
Shares of the volatile Hemispherx BioPharma (AMEX: HEB) are continuing lower today following yesterday's update on Ampligen and the resulting 8% drop in the stock. Today, Hemispherx has tumbled more than 15%.
Notably, over the last two weeks (since October 21), shares of Hemispherx have sunk by more than 45% from $1.80 to around $1.13 today. Unfortunately for the bulls, volume during this period has been, on average, pretty heavy.
Notably, over the last two weeks (since October 21), shares of Hemispherx have sunk by more than 45% from $1.80 to around $1.13 today. Unfortunately for the bulls, volume during this period has been, on average, pretty heavy.
You May Also Be Interested In
- Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point
- Billionaire Trashes Facebook (FB) IPO, Then Buys a Slug of Stock
- Mattress Stocks Zip Higher on Positive Comments (TPX) (SCSS) (ZZ) (MFRM)
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
